CD8A and graft versus host disease: HLA-A2-specific CAR CD4+ Tregs have greater regulatory GVHD abilities than polyclonal CD4+ Tregs (93), and accordingly, HLA-A2-specific CAR CD8+ Tregs are reported to prevent GVHD more effectively (94).